UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A25-A25

2024

Volltextzugriff (PDF)

09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A3-A4

2022

Volltextzugriff (PDF)

P09.01 Single-cell transcriptomic atlas-guided development of chimeric antigen-receptor (CAR) T cells for the treatment of acute myeloid leukemia

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A31-A31

2022

Volltextzugriff (PDF)

OS03.4.A In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii12-ii12

2022

Volltextzugriff (PDF)

Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models

European journal of cancer (1990), 2019-03, Vol.110, p.S3-S3

2019

Volltextzugriff (PDF)

A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors

European journal of cancer (1990), 2019-03, Vol.110, p.S25-S25

2019

Volltextzugriff (PDF)

P08.06 Combining RIG-I-targeted immune activation with CAR T cell therapy induces efficient tumor control in murine pancreatic cancer models

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A27-A27

2021

Volltextzugriff (PDF)

Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors

European journal of cancer (1990), 2018-03, Vol.92, p.S19-S19

2018

Volltextzugriff (PDF)

Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models

European journal of cancer (1990), 2018-03, Vol.92, p.S20-S20

2018

Volltextzugriff (PDF)

Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer

European journal of cancer (1990), 2019-03, Vol.110, p.S25-S26

2019

Volltextzugriff (PDF)

P08.05 Combined pharmacological targeting of adenosine 2a- and 2b-receptor enhances CAR T cell function

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A26-A27

2021

Volltextzugriff (PDF)

10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A1-A1

2021

Volltextzugriff (PDF)

P06.06 Enhancing trafficking and resistance to immunosuppression of synthetic agonistic receptor-transduced T cells in solid tumor models

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A21-A22

2021

Volltextzugriff (PDF)

P06.07 CXCR6 expression enhances accumulation of anti-mesothelin CAR T cells at the tumor site and their therapeutic efficacy in pancreatic cancer xenografts

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A44-A44

2020

Volltextzugriff (PDF)

P06.01 Bispecific antibody-driven synthetic agonistic receptor – transduced T cells mediate specific and conditional therapy in melanoma cancer models

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A41-A42

2020

Volltextzugriff (PDF)

P06.03 C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A42-A43

2020

Volltextzugriff (PDF)

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A4-A5

2022

Volltextzugriff (PDF)

L4 Synthetic agonistic receptor-activating BiTEs – a modular platform for the efficient targeting of acute myeloid leukemia

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A2-A3

2020

Volltextzugriff (PDF)

P06.05 IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models

Journal for immunotherapy of cancer, 2020-10, Vol.8 (Suppl 2), p.A43-A43

2020

Volltextzugriff (PDF)

P06.03 Bispecific antibody-driven synthetic agonistic receptor engineered T cells lead to specific and conditional therapy in melanoma cancer models

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A20-A20

2021

Volltextzugriff (PDF)

P07.01 A modular and controllable T cell therapy platform for AML

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A22-A23

2021

Volltextzugriff (PDF)

Congenital muscular torticollis: where are we today? A retrospective analysis at a tertiary hospital

Porto biomedical journal, 2019-05, Vol.4 (3), p.e36-e36

2019

Volltextzugriff (PDF)

An Inkjet-Printed Low-Voltage Latch Based on Inorganic Electrolyte-Gated Transistors

IEEE electron device letters, 2018-06, Vol.39 (6), p.831-834

2018

Volltextzugriff (PDF)

A Smooth EKV-Based DC Model for Accurate Simulation of Printed Transistors and Their Process Variations

IEEE transactions on electron devices, 2018-02, Vol.65 (2), p.667-673

2018

Volltextzugriff (PDF)

Influence of Humidity on the Performance of Composite Polymer Electrolyte-Gated Field-Effect Transistors and Circuits

IEEE transactions on electron devices, 2019-05, Vol.66 (5), p.2202-2207

2019

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(35)
Tagungsberichte
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Lymphocytes
(15)
Immunotherapy
(14)
Science & Technology
(14)
Engineering
(12)
Engineering, Electrical & Electronic
(12)
Technology
(12)
Antigens
(11)
Logic Gates
(10)
Transistors
(10)
Electrolytes
(7)
Physical Sciences
(7)
Physics
(7)
Physics, Applied
(7)
Printed Electronics
(7)
Semiconductor Devices
(7)
Tumors
(7)
Electrolyte-Gated Transistors
(5)
Field Effect Transistors
(5)
Integrated Circuit Modeling
(5)
Cancer
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression

09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models

P09.01 Single-cell transcriptomic atlas-guided development of chimeric antigen-receptor (CAR) T cells for the treatment of acute myeloid leukemia

OS03.4.A In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer

Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models

A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors

P08.06 Combining RIG-I-targeted immune activation with CAR T cell therapy induces efficient tumor control in murine pancreatic cancer models

Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors

Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models

Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer

P08.05 Combined pharmacological targeting of adenosine 2a- and 2b-receptor enhances CAR T cell function

10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells

P06.06 Enhancing trafficking and resistance to immunosuppression of synthetic agonistic receptor-transduced T cells in solid tumor models

P06.07 CXCR6 expression enhances accumulation of anti-mesothelin CAR T cells at the tumor site and their therapeutic efficacy in pancreatic cancer xenografts

P06.01 Bispecific antibody-driven synthetic agonistic receptor – transduced T cells mediate specific and conditional therapy in melanoma cancer models

P06.03 C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

L4 Synthetic agonistic receptor-activating BiTEs – a modular platform for the efficient targeting of acute myeloid leukemia

P06.05 IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models

P06.03 Bispecific antibody-driven synthetic agonistic receptor engineered T cells lead to specific and conditional therapy in melanoma cancer models

P07.01 A modular and controllable T cell therapy platform for AML

Congenital muscular torticollis: where are we today? A retrospective analysis at a tertiary hospital

An Inkjet-Printed Low-Voltage Latch Based on Inorganic Electrolyte-Gated Transistors

A Smooth EKV-Based DC Model for Accurate Simulation of Printed Transistors and Their Process Variations

Influence of Humidity on the Performance of Composite Polymer Electrolyte-Gated Field-Effect Transistors and Circuits

Suchergebnisse filtern